BD Acquires Vancouver Washington-based Leading RFID Pharmacy Technology Company, GSL Solutions

BD (Becton, Dickinson and Company), a leading global medical technology company, has acquired GSL Solutions, Inc. (GSL), a privately-held company that develops smart medication devices for the storage and tracking of controlled substances and patient specific medications,This acquisition expands BD's advanced medication management capabilities to further meet the needs of retail pharmacies, including those in outpatient settings."This strategic acquisition provides innovative technologies for retail pharmacies and builds on recent acquisitions that have complemented our traditional hospital pharmacy connected medication management solutions," said Mike Garrison, worldwide president of medication management solutions at BD. "Market consolidation, larger numbers of prescriptions written and changing regulations for controlled substances are intensifying the need for accurate, automated tracking of prescription medications and narcotics. This acquisition will help enable a new suite of BD products and services for retail and outpatient pharmacy customers to meet their current and future needs."GSL's RFID-based products include standalone cabinets that provide secure storage for will-call prescriptions and automatically notify patients when prescriptions are ready, and secured cabinets for controlled substances. This all helps pharmacies run more efficient and profitably and shortens wait time for patients."GSL utilizes advanced technology to create secure medication management systems that give retail pharmacists end-to-end solutions that alleviate the administrative burden, while ensuring compliance and patient satisfaction," said Shelton Louie, GSL Solutions co-founder and CEO. "By joining BD, we look forward to maximizing the benefits of our products and technology and helping pharmacies manage their increasingly complex business and regulatory environments."BD looks forward to welcoming GSL's approximately 20 full-time associates, headquartered in Vancouver, Washington.GSL is the fourth tuck-in acquisition that BD has completed in fiscal 2021. Terms of the transaction were not disclosed. BD expects the transaction to be immaterial.BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!